Dror Avni

2.7k total citations
39 papers, 2.0k citations indexed

About

Dror Avni is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dror Avni has authored 39 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 13 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Dror Avni's work include MicroRNA in disease regulation (10 papers), RNA Research and Splicing (8 papers) and RNA Interference and Gene Delivery (6 papers). Dror Avni is often cited by papers focused on MicroRNA in disease regulation (10 papers), RNA Research and Splicing (8 papers) and RNA Interference and Gene Delivery (6 papers). Dror Avni collaborates with scholars based in Israel, United States and United Kingdom. Dror Avni's co-authors include Oded Meyuhas, Yechezkel Sidi, Narayanan Hariharan, Shoshana Levy, Robert P. Perry, Raya Leibowitz‐Amit, Fabrizio Loreni, David M. Livingston, Aviv Barzilai and Galya Lerman and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Dror Avni

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dror Avni Israel 21 1.5k 478 352 267 207 39 2.0k
T Nakagawa United States 15 1.4k 0.9× 385 0.8× 200 0.6× 917 3.4× 201 1.0× 18 2.6k
Matthew C. Biery United States 17 1.0k 0.7× 500 1.0× 213 0.6× 393 1.5× 218 1.1× 29 1.6k
Catrina C. Fronick United States 18 1.2k 0.8× 343 0.7× 358 1.0× 393 1.5× 90 0.4× 34 2.1k
Jonathan P. Butchar United States 28 1.1k 0.7× 278 0.6× 424 1.2× 1.0k 3.9× 185 0.9× 58 2.3k
Lorea Manterola Spain 21 1.2k 0.8× 876 1.8× 230 0.7× 182 0.7× 75 0.4× 27 1.8k
Chris Kingsley United States 11 1.3k 0.9× 167 0.3× 237 0.7× 281 1.1× 250 1.2× 14 1.9k
Sergej Djuranović United States 18 1.7k 1.1× 783 1.6× 86 0.2× 135 0.5× 258 1.2× 33 2.0k
Wera Roth Germany 13 1.1k 0.7× 509 1.1× 233 0.7× 555 2.1× 155 0.7× 13 2.1k
Peter B. Dallas Australia 16 971 0.7× 193 0.4× 191 0.5× 153 0.6× 145 0.7× 28 1.4k

Countries citing papers authored by Dror Avni

Since Specialization
Citations

This map shows the geographic impact of Dror Avni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dror Avni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dror Avni more than expected).

Fields of papers citing papers by Dror Avni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dror Avni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dror Avni. The network helps show where Dror Avni may publish in the future.

Co-authorship network of co-authors of Dror Avni

This figure shows the co-authorship network connecting the top 25 collaborators of Dror Avni. A scholar is included among the top collaborators of Dror Avni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dror Avni. Dror Avni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avni, Dror, Michal Solomon, Merav Strauss, et al.. (2024). The Epidemiology of PCR-Confirmed Cutaneous Leishmaniasis in Israel: A Nationwide Study. Microorganisms. 12(10). 1950–1950. 1 indexed citations
2.
Avni, Dror & Orly Avni. (2021). Extracellular Vesicles: Schistosomal Long-Range Precise Weapon to Manipulate the Immune Response. Frontiers in Cellular and Infection Microbiology. 11. 649480–649480. 14 indexed citations
3.
Hizi, Amnon, et al.. (2021). Mitochondrial matrix-localized p53 participates in degradation of mitochondrial RNAs. Mitochondrion. 58. 200–212.
4.
Meningher, Tal, Yiftah Barsheshet, Yifat Ofir‐Birin, et al.. (2019). Schistosomal extracellular vesicle‐enclosed miRNAs modulate host T helper cell differentiation. EMBO Reports. 21(1). e47882–e47882. 72 indexed citations
5.
Meningher, Tal, Iris Barshack, Devorah Gur‐Wahnon, et al.. (2019). Giardia lamblia miRNAs as a new diagnostic tool for human giardiasis. PLoS neglected tropical diseases. 13(6). e0007398–e0007398. 11 indexed citations
6.
Roszik, Jason, Ettai Markovits, Paula Dobosz, et al.. (2019). TNFSF4 (OX40L) expression and survival in locally advanced and metastatic melanoma. Cancer Immunology Immunotherapy. 68(9). 1493–1500. 19 indexed citations
7.
Lerman, Galya, Tal Meningher, Aviv Barzilai, et al.. (2018). Ultrasound targeting of Q-starch/miR-197 complexes for topical treatment of psoriasis. Journal of Controlled Release. 284. 103–111. 38 indexed citations
8.
Kopel, Eli, Ariel Feiglin, Dror Avni, et al.. (2018). Decreased A-to-I RNA editing as a source of keratinocytes' dsRNA in psoriasis. RNA. 24(6). 828–840. 34 indexed citations
9.
Mizrahi, Adi, Aviv Barzilai, Devorah Gur‐Wahnon, et al.. (2017). Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes. Oncogene. 37(2). 218–230. 44 indexed citations
10.
Lerman, Galya, Michal Sharon, Raya Leibowitz‐Amit, Yechezkel Sidi, & Dror Avni. (2014). The Crosstalk between IL-22 Signaling and miR-197 in Human Keratinocytes. PLoS ONE. 9(9). e107467–e107467. 50 indexed citations
11.
Avraham, Roi, Aviv Barzilai, Roy Navon, et al.. (2012). Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Molecular Cancer. 11(1). 44–44. 114 indexed citations
12.
Lerman, Galya, Camila Avivi, Aviv Barzilai, et al.. (2011). MiRNA Expression in Psoriatic Skin: Reciprocal Regulation of hsa-miR-99a and IGF-1R. PLoS ONE. 6(6). e20916–e20916. 113 indexed citations
13.
Lerman, Galya, et al.. (2010). Small-interfering RNA targeted at antiapoptotic mRNA increases keratinocyte sensitivity to apoptosis. British Journal of Dermatology. 164(5). 947–956. 8 indexed citations
14.
Avni, Dror, Hong Yang, Fabio Martelli, et al.. (2003). Active Localization of the Retinoblastoma Protein in Chromatin and Its Response to S Phase DNA Damage. Molecular Cell. 12(3). 735–746. 101 indexed citations
15.
Ganesan, Shridar, Daniel P. Silver, Roger A. Greenberg, et al.. (2002). BRCA1 Supports XIST RNA Concentration on the Inactive X Chromosome. Cell. 111(3). 393–405. 226 indexed citations
16.
Hornstein, Eran, Anna Git, Ilana Braunstein, Dror Avni, & Oded Meyuhas. (1999). The Expression of Poly(A)-binding Protein Gene Is Translationally Regulated in a Growth-dependent Fashion through a 5′-Terminal Oligopyrimidine Tract Motif. Journal of Biological Chemistry. 274(3). 1708–1714. 62 indexed citations
17.
18.
Avni, Dror, et al.. (1997). The 5' Terminal Oligopyrimidine Tract Confers Translational Control on Top Mrnas in a Cell Type-and Sequence Context-Dependent Manner. Nucleic Acids Research. 25(5). 995–1001. 109 indexed citations
19.
Meyuhas, Oded, et al.. (1996). 13 Translational Control of Ribosomal Protein mRNAs in Eukaryotes. Cold Spring Harbor Monograph Archive. 30. 363–364. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026